Aurobindo Pharma Limited has informed the Exchange about update on acquisition of 26% stake in Swarnaakshu Solar Power Private Limited
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aurobindo Pharma has informed the exchange that its planned acquisition of up to 26% stake in Swarnaakshu Solar Power Private Limited has been delayed beyond the original deadline of December 31, 2025. The delay is due to pending approval from the state government for setting up a captive solar power plant. The company now expects to complete the 26% investment on or before March 31, 2026, subject to receiving the required government approval. This acquisition is linked to a captive solar power purchase agreement, aimed at meeting the company's renewable energy needs. This is the fourth update on this matter, with prior communications dated February, March, June, and September 2025.
Minor delay in a strategic clean-energy investment; no immediate impact on core pharma business, but shareholders should note the extended timeline contingent on regulatory approvals.